Synthesis of Novel Pyrazolo[5,1-b][1,3]benzothiazoles: A New Pericyclic Pathway

Tekiner-Gülbaş, Betül; Filák, László; Vaskó, Gyöngyvér Ágnes; Egyed, Orsolya; Yalçın, İsmail; Aki-Sener, Esin; Riedl, Zsuzsanna; Hajós, György

doi:10.3987/com-08-11355

Cited by 7 publications

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

ChemInform Abstract: Synthesis of Novel Pyrazolo[5,1‐b]benzothiazoles: A New Pericyclic Pathway.

Tekiner‐Gulbas¹,

Filák²,

Vasko³

et al. 2008

ChemInform

View full text Add to dashboard Cite

Benzothiazole derivatives R 0270Synthesis of Novel Pyrazolo[5,1-b]benzothiazoles: A New Pericyclic Pathway. -N-Amination of the benzylbenzothiazoles (I), followed by reaction of the N-amino salts (III) with ethyl orthoformate (IV) afford derivatives (V) of the pyrazolobenzothiazole ring system. The ring closure may proceed via deprotonation of the N-amino salt and subsequent electrocyclization to provide the tricyclic ring system. From a theoretical point of view, the pericyclic nature of the ring-closure step is of importance. -(TEKINER-GULBAS, B.; FILAK, L.; VASKO, G. A.; EGYED, O.; YALCIN, I.; AKI-SENER, E.; RIEDL, Z.; HAJOS*, G.; Heterocycles 75 (2008) 8, 2005-2012; Chem. Res. Cent., Hung. Acad. Sci., H-1025 Budapest, Hung.; Eng.) -H. Hoennerscheid 50-123

show abstract

ChemInform Abstract: Synthesis of Novel Pyrazolo[5,1‐b]benzothiazoles: A New Pericyclic Pathway.

Tekiner‐Gulbas¹,

Filák²,

Vasko³

et al. 2008

ChemInform

View full text Add to dashboard Cite

show abstract

Benzothiazole derivatives as human DNA topoisomerase IIα inhibitors

et al. 2013

View full text Add to dashboard Cite

Benzothiazole derivatives resembling the structure of DNA purine bases were tested to determine their topoisomerase inhibition activities. Based on DNA topoisomerase I and II relaxation assay results, all 12 derivatives acted as human topoisomerase IIa inhibitors, whereas only two compounds inhibited Calf thymus topoisomerase I. 3-amino-2-(2-bromobenzyl)-1,3-benzothiazol-3-ium 4-methylbenzensulfonate (BM3) was observed to be the most effective human topoisomerase IIa inhibitor with the lowest IC 50 value of 39 nM. The mechanistic studies suggested that BM3 was neither a DNA intercalator nor a topoisomerase poison, it was only a DNA minor groovebinding agent. BM3 initially bound to the DNA topoisomerase IIa enzyme, then to DNA. As a result, the tested benzothiazole derivatives were obtained as strong topoisomerase IIa inhibitors. The benzothiazole tosylated salt form BM3 was found as the most effective topoisomerase IIa inhibitor. BM3's mechanisms of action might be its direct interaction with the enzyme. BM3's minor groove-binding property might also contribute to this action. Hence, BM3 could be a good candidate as a new anticancer agent.

show abstract